Page last updated: 2024-10-23

azathioprine and Facial Hemiatrophy

azathioprine has been researched along with Facial Hemiatrophy in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hernández Pérez, JM1
Acosta Fernández, O1
Goldenstein-Schainberg, C1
Pereira, RM1
Gusukuma, MC1
Messina, WC1
Cossermelli, W1

Other Studies

2 other studies available for azathioprine and Facial Hemiatrophy

ArticleYear
[Lung disease secondary to morphea en coup de sabre, a form of localized scleroderma].
    Archivos de bronconeumologia, 2009, Volume: 45, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Azathioprine; Drug Therapy, Combination; Facial Hemi

2009
Childhood linear scleroderma "en coup de sabre" with uveitis.
    The Journal of pediatrics, 1990, Volume: 117, Issue:4

    Topics: Autoantibodies; Azathioprine; Child; Diagnosis, Differential; Facial Hemiatrophy; Humans; Male; Peni

1990